Food & Health
Key takeaways: Incyte’s experimental drug, povorcitinib, has met its primary endpoint in two Phase 3 studies. Despite this success, Incyte shares fell sharply due to underwhelming results compared to previous trials. The drug targets hidradenitis suppurativa, a painful skin condition affecting...
Key takeaways: Stefano Pessina will nearly double his stake in Walgreens Boots Alliance to approximately...
Key takeaways: Google has expanded its healthcare AI updates, enhancing the Search experience with more...
Key takeaways: PepsiCo has announced the acquisition of prebiotic soda brand Poppi for $1.95 billion....
UnitedHealth Group (UNH-7.15%) is facing a civil fraud investigation by the U.S. Department of Justice...
Coca-Cola reported stronger-than-expected quarterly earnings and revenue on Tuesday, driven by robust...
Cocoa prices have skyrocketed to unprecedented levels, surging above the once-unthinkable mark of $10,000...
Trending
CATEGORIES
Categories
Categories
SIGNUP TO OUR NEWSLETTER
Subscribe
Get breaking market insights directly to your inbox
